127 related articles for article (PubMed ID: 30145821)
1. Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.
Biray Avci C; Dogan F; Ozates Ay NP; Goker Bagca B; Abbaszadeh Z; Gunduz C
J Cell Biochem; 2018 Dec; 119(12):9817-9824. PubMed ID: 30145821
[TBL] [Abstract][Full Text] [Related]
2. A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
Shi Y; Sun L; Chen G; Zheng D; Li L; Wei W
Target Oncol; 2015 Dec; 10(4):565-73. PubMed ID: 25916999
[TBL] [Abstract][Full Text] [Related]
3. Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line.
Pourbagheri-Sigaroodi A; Bashash D; Safaroghli-Azar A; Farshi-Paraasghari M; Momeny M; Mansoor FN; Ghaffari SH
Eur J Pharmacol; 2019 Mar; 846():49-62. PubMed ID: 30658112
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract][Full Text] [Related]
5. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
[TBL] [Abstract][Full Text] [Related]
6. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
El-Daly H; Kull M; Zimmermann S; Pantic M; Waller CF; Martens UM
Blood; 2005 Feb; 105(4):1742-9. PubMed ID: 15507522
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Bashash D; Zareii M; Safaroghli-Azar A; Omrani MD; Ghaffari SH
Hematology; 2017 Jul; 22(6):330-340. PubMed ID: 28054503
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
Kusoglu A; Goker Bagca B; Ozates Ay NP; Gunduz C; Biray Avci C
Gene; 2020 Oct; 759():145001. PubMed ID: 32738420
[TBL] [Abstract][Full Text] [Related]
9. A Non-Toxic Concentration of Telomerase Inhibitor BIBR1532 Fails to Reduce
Pandya VA; Crerar H; Mitchell JS; Patani R
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806803
[TBL] [Abstract][Full Text] [Related]
10. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors.
Mueller S; Hartmann U; Mayer F; Balabanov S; Hartmann JT; Brummendorf TH; Bokemeyer C
Invest New Drugs; 2007 Dec; 25(6):519-24. PubMed ID: 17534576
[TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
Bashash D; Ghaffari SH; Mirzaee R; Alimoghaddam K; Ghavamzadeh A
Leuk Lymphoma; 2013 Mar; 54(3):561-8. PubMed ID: 22957790
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532.
Liu C; Zhou H; Sheng XB; Liu XH; Chen FH
Bioorg Chem; 2020 Sep; 102():104077. PubMed ID: 32682156
[TBL] [Abstract][Full Text] [Related]
13. Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways.
Rafat A; Dizaji Asl K; Mazloumi Z; Movassaghpour AA; Talebi M; Shanehbandi D; Farahzadi R; Nejati B; Nozad Charoudeh H
Life Sci; 2022 Apr; 295():120402. PubMed ID: 35176279
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Ward RJ; Autexier C
Mol Pharmacol; 2005 Sep; 68(3):779-86. PubMed ID: 15939802
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Pascolo E; Wenz C; Lingner J; Hauel N; Priepke H; Kauffmann I; Garin-Chesa P; Rettig WJ; Damm K; Schnapp A
J Biol Chem; 2002 May; 277(18):15566-72. PubMed ID: 11854300
[TBL] [Abstract][Full Text] [Related]
16. [The influence of compound aITEL1296 on telomerase activity and the growth of cancer cells].
Kovalenko NA; Zhdanov DD; Bibikova MV; Gotovtseva VIu
Biomed Khim; 2011; 57(5):501-10. PubMed ID: 22629600
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.
Bryan C; Rice C; Hoffman H; Harkisheimer M; Sweeney M; Skordalakes E
Structure; 2015 Oct; 23(10):1934-1942. PubMed ID: 26365799
[TBL] [Abstract][Full Text] [Related]
18. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells.
Meng E; Taylor B; Ray A; Shevde LA; Rocconi RP
Gynecol Oncol; 2012 Mar; 124(3):598-605. PubMed ID: 22115853
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of telomerase causes vulnerability to endoplasmic reticulum stress-induced neuronal cell death.
Hosoi T; Nakatsu K; Shimamoto A; Tahara H; Ozawa K
Neurosci Lett; 2016 Aug; 629():241-244. PubMed ID: 27443785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
